Piśmiennictwo

[1] di Costanzo J, Sastre B, Choux R, et al. Mechanism of thrombogenesis during total parenteral nutrition: role of catheter composition. JPEN J Parenter Enteral Nutr 1988;12:190-194.

[2] Mehall JR, Saltzman DA, Jackson RJ, et al. Catheter materials affect the incidence of late blood-borne catheter infection. Surg Infect (Larchmt) 2001;2:225-229, discussion 229-230.

[3] Mehall JR, Saltzman DA, Jackson RJ, et al. Fibrin sheath enhances central venous catheter infection. Crit Care Med 2002;30:908-912.

[4] Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994;62:915-921.

[5] Niederhuber JE, Ensminger W, Gyves JW, et al. Totally implanted venous and arterial access system to replace external catheter in cancer treatment. Surgery 1982;92:706-712.

[6] Gyves J, Ensminger W, Niederhuber J, et al. Totally implanted system for intravenous chemotherapy in patients with cancer. Am J Med 1982;73:841-845.

[7] Bothe A Jr, Piccione W, Ambrosino JJ, et al. Implantable central venous access system. Am J Surg 1984;147:565-569.

[8] Bland KI, Woodcock T. Totally implantable venous access system for cyclic administration of cytotoxic chemotherapy. Am J Surg 1984;147:815-816.

[9] Craus W, Di Giacomo A, Tommasino U, et al. Totally Implantable Central Venous Access: 15 years' experience in a single unit. J Vasc Access 2001;2:161-167.

[10] Ignatov A, Hoffman O, Smith B, et al. An 11-year retrospective study of totally implanted central venous access ports: Complications and patient satisfaction. Eur J Surg Oncol 2009;35:241-246.

[11] Kreis H, Loehberg CR, Lux MP, et al. Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies. Eur J Surg Oncol 2007;33:39-43.

[12] Bow EJ, Kilpatrick MG, Clinch JJ. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol 1999;17:1267.

[13] Jarosz J, Misiak M, Góraj E, et al. Wszczepialne systemy dostępu naczyniowego o długotrwałym zastosowaniu („porty”) – standardy 2011. Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych, 2011 r., t. I:571-582.

[14] Kolb S, Grätsch A, Sailer D, et al. Implantable ports. A new method for long-term home parenteral nutrition. Fortschr Med 1985;103:790-792.

[15] Jauch KW, Schregel W, Stanga Z, et al. Access technique and its problems in parenteral nutrition – Guidelines on Parenteral Nutrition, Chapter 9. Ger Med Sci 2009;7: Doc19.

[16] Pittiruti M, Hamilton H, Biffi R, et al. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr 2009;28:365-377.

[17] Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81:1159-1171.

[18] Ng F, Mastoroudes H, Paul E, et al. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy. Clin Oncol (R Coll Radiol) 2007;19:551-556.

[19] Chang L, Tsai JS, Huang SJ, et al. Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control 2003;31:34-39.

[20] Goltz JP, Noack C, Petritsch B. Totally implantable venous power ports of the forearm and the chest: initial clinical experience with port devices approved for high-pressure injections. Br J Radiol 2012;85:e966-972.

[21] Abad Rico JI, Llau Pitarch JV, Páramo Fernández JA. Topical issues in venous thromboembolism. Drugs 2010;70 Suppl 2:11-18.

[22] Korte W, Cattaneo M, Chassot PG, et al. Peri-operative management of antiplatelet therapy in patients with coronary artery disease. Joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost 2011;105(5).

[23] Cavanna L, Civardi G, Vallisa D, et al. Ultrasound-guided central venous catheterization in cancer patients improves the success rate of cannulation and reduces mechanical complications: A prospective observational study of 1,978 consecutive catheterizations. World Journal of Surgical Oncology 2010:8:91.

[24] Vardy J, Engelhardt K, Cox K, et al. Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer 2004;91:1045-1049.

[25] Vesely TM. Central Venous Catheter Tip Position: A Continuing Controversy. J Vasc Interv Radiol 2003;14:527-534.

[26] van Rooden CJ, Tesselaar MET, Osanto S, et al. Deep vein thrombosis associated with central venous catheters – a review. J Thromb Haemost 2005;3:2409-2419.

[27] Vezzani A, Brusasco C, Palermo S, et al. Ultrasound localization of central vein catheter and detection of postprocedural pneumothorax: an alternative to chest radiography. Crit Care Med 2010;38:533-538.

[28] Lee JH, Bahk JH, Ryu HG, et al. Comparison of the bedside central venous catheter placement techniques: landmark vs electrocardiogram guidance. Br J Anaesth 2009;102:662-666.

[29] Wang YC, Huang CH, Lin FS, et al. Intravenous electrocardiography helps inexperienced operators to place totally implantable venous access device more accurately. J Surg Oncol 2012;105:848-851.

[30] Pittiruti M, Bertollo D, Briglia E, et al. The intracavitary ECG method for positioning the tip of central venous catheters: results of an Italian multicenter study. J Vasc Access 2012;13:357-365.

[31] Guilbert MC, Elkouri S, Bracco D, et al. Arterial trauma during central venous catheter insertion: Case series, review and proposed algorithm. J Vasc Surg 2008;48:918-925.

[32] Sitzmann JV, Townsend TR, Siler MC, et al. Septic and technical complications of central venous catheterization. A prospective study of 200 consecutive patients. Ann Surg 1985;202:66-770.

[33] Yilmazlar A, Bilgin H, Korfali G, et al. Complications of 1303 central venous cannulations. J R Soc Med 1997;90:319-321.

[34] Kusminsky RE. Complications of Central Venous Catheterization. J Am Coll Surg 2007;204:681-696.

[35] Di Carlo I, Biffi R. Totally Implantable Venous Access Devices. Springer 2012 edition:227-229.

[36] van de Wetering MD, van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev 2007;(1):CD003295.

[37] Covey AM, Toro-Pape FW, Thornton RH, et al. Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary? J Vasc Interv Radiol 2012;23:358-362.

[38] Gebauer B, Teichgräber U, Werk M, et al. Periinterventional prophylactic antibiotics in radiological port catheter implantation. RoFo 2007;179:804–810.

[39] Lapalu J, Losser MR, Albert O, et al. Totally implantable port management: impact of positive pressure during needle withdrawal on catheter tip occlusion (an experimental study). J Vasc Access 2010;11:46-51.

[40] Guiffant G, Durussel JJ, Flaud P, et al. Flushing ports of totally implantable venous access devices, and impact of the Huber point needle bevel orientation: experimental tests and numerical computation. Med Devices (Auckl) 2012;5:31-37.

[41] Bertoglio S, Solari N, Meszaros P, et al. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nurs 2012;35:E35-42.